Literature DB >> 27334596

BZLF1 Attenuates Transmission of Inflammatory Paracrine Senescence in Epstein-Barr Virus-Infected Cells by Downregulating Tumor Necrosis Factor Alpha.

Xubing Long1, Yuqing Li2, Mengtian Yang2, Lu Huang2, Weijie Gong3, Ersheng Kuang4.   

Abstract

UNLABELLED: Recent studies have shown that inflammatory responses trigger and transmit senescence to neighboring cells and activate the senescence-associated secretory phenotype (SASP). Latent Epstein-Barr virus (EBV) infection induces increased secretion of several inflammatory factors, whereas lytic infections evade the antiviral inflammatory response. However, the changes in and roles of the inflammatory microenvironment during the switch between EBV life cycles remain unknown. In the present study, we demonstrate that latent EBV infection in EBV-positive cells triggers the SASP in neighboring epithelial cells. In contrast, lytic EBV infection abolishes this phenotype. BZLF1 attenuates the transmission of paracrine senescence during lytic EBV infection by downregulating tumor necrosis factor alpha (TNF-α) secretion. A mutant BZLF1 protein, BZLF1Δ207-210, that cannot inhibit TNF-α secretion while maintaining viral transcription, fails to block paracrine senescence, whereas a neutralizing antibody against TNF-α is sufficient to restore its inhibition. Furthermore, latent EBV infection induces oxidative stress in neighboring cells, while BZLF1-mediated downregulation of TNF-α reduces reactive oxygen species (ROS) levels in neighboring cells, and ROS scavengers alleviate paracrine senescence. These results suggest that lytic EBV infection attenuates the transmission of inflammatory paracrine senescence through BZLF1 downregulation of TNF-α secretion and alters the inflammatory microenvironment to allow virus propagation and persistence. IMPORTANCE: The senescence-associated secretory phenotype (SASP), an important tumorigenic process, is triggered and transmitted by inflammatory factors. The different life cycles of Epstein-Barr virus (EBV) infection in EBV-positive cells employ distinct strategies to modulate the inflammatory response and senescence. The elevation of inflammatory factors during latent EBV infection promotes the SASP in uninfected cells. In contrast, during the viral lytic cycle, BZLF1 suppresses the production of TNF-α, resulting in the attenuation of paracrine inflammatory senescence. This finding indicates that EBV evades inflammatory senescence during lytic infection and switches from facilitating tumor-promoting SASP to generating a virus-propagating microenvironment, thereby facilitating viral spread in EBV-associated diseases.
Copyright © 2016, American Society for Microbiology. All Rights Reserved.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 27334596      PMCID: PMC4988136          DOI: 10.1128/JVI.00999-16

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  57 in total

1.  Genetic dissection of cell growth arrest functions mediated by the Epstein-Barr virus lytic gene product, Zta.

Authors:  A Rodriguez; M Armstrong; D Dwyer; E Flemington
Journal:  J Virol       Date:  1999-11       Impact factor: 5.103

2.  Requirement for cell-to-cell contact in Epstein-Barr virus infection of nasopharyngeal carcinoma cells and keratinocytes.

Authors:  Y Chang; C H Tung; Y T Huang; J Lu; J Y Chen; C H Tsai
Journal:  J Virol       Date:  1999-10       Impact factor: 5.103

3.  The Epstein-Barr virus lytic program is controlled by the co-operative functions of two transactivators.

Authors:  R Feederle; M Kost; M Baumann; A Janz; E Drouet; W Hammerschmidt; H J Delecluse
Journal:  EMBO J       Date:  2000-06-15       Impact factor: 11.598

Review 4.  Interplay among viral antigens, cellular pathways and tumor microenvironment in the pathogenesis of EBV-driven lymphomas.

Authors:  Riccardo Dolcetti; Jessica Dal Col; Debora Martorelli; Antonino Carbone; Eva Klein
Journal:  Semin Cancer Biol       Date:  2013-08-03       Impact factor: 15.707

5.  The Epstein-Barr virus bZIP transcription factor Zta causes G0/G1 cell cycle arrest through induction of cyclin-dependent kinase inhibitors.

Authors:  C Cayrol; E K Flemington
Journal:  EMBO J       Date:  1996-06-03       Impact factor: 11.598

Review 6.  Evasion of oncogene-induced senescence by gammaherpesviruses.

Authors:  Andrew M Leidal; Eric S Pringle; Craig McCormick
Journal:  Curr Opin Virol       Date:  2012-10-12       Impact factor: 7.090

Review 7.  Immune escape of γ-herpesviruses from adaptive immunity.

Authors:  Zhuting Hu; Edward J Usherwood
Journal:  Rev Med Virol       Date:  2014-04-15       Impact factor: 6.989

Review 8.  Cellular responses to viral infection in humans: lessons from Epstein-Barr virus.

Authors:  Andrew D Hislop; Graham S Taylor; Delphine Sauce; Alan B Rickinson
Journal:  Annu Rev Immunol       Date:  2007       Impact factor: 28.527

9.  A complex secretory program orchestrated by the inflammasome controls paracrine senescence.

Authors:  Juan Carlos Acosta; Ana Banito; Torsten Wuestefeld; Athena Georgilis; Peggy Janich; Jennifer P Morton; Dimitris Athineos; Tae-Won Kang; Felix Lasitschka; Mindaugas Andrulis; Gloria Pascual; Kelly J Morris; Sadaf Khan; Hong Jin; Gopuraja Dharmalingam; Ambrosius P Snijders; Thomas Carroll; David Capper; Catrin Pritchard; Gareth J Inman; Thomas Longerich; Owen J Sansom; Salvador Aznar Benitah; Lars Zender; Jesús Gil
Journal:  Nat Cell Biol       Date:  2013-06-16       Impact factor: 28.824

10.  Oxidative stress activates a specific p53 transcriptional response that regulates cellular senescence and aging.

Authors:  Valentina Gambino; Giulia De Michele; Oriella Venezia; Pierluigi Migliaccio; Valentina Dall'Olio; Loris Bernard; Simone Paolo Minardi; Maria Agnese Della Fazia; Daniela Bartoli; Giuseppe Servillo; Myriam Alcalay; Lucilla Luzi; Marco Giorgio; Heidi Scrable; Pier Giuseppe Pelicci; Enrica Migliaccio
Journal:  Aging Cell       Date:  2013-03-27       Impact factor: 9.304

View more
  6 in total

Review 1.  Role of Epstein-Barr virus in transformation of follicular lymphoma to diffuse large B-cell lymphoma: a case report and review of the literature.

Authors:  Massimo Granai; Maria Raffaella Ambrosio; Ayse Akarca; Lucia Mundo; Federica Vergoni; Raffaella Santi; Virginia Mancini; Gioia di Stefano; Teresa Amato; Cristiana Bellan; Benedetta Puccini; Ester Sorrentino; Kikkeri N Naresh; Lorenzo Leoncini; Teresa Marafioti; Stefano Lazzi
Journal:  Haematologica       Date:  2019-03-07       Impact factor: 9.941

Review 2.  Evolving insights into the genomic complexity and immune landscape of diffuse large B-cell lymphoma: opportunities for novel biomarkers.

Authors:  Siba El Hussein; Kenna R M Shaw; Francisco Vega
Journal:  Mod Pathol       Date:  2020-07-03       Impact factor: 7.842

Review 3.  Circulating miRNAs and miRNA shuttles as biomarkers: Perspective trajectories of healthy and unhealthy aging.

Authors:  Fabiola Olivieri; Miriam Capri; Massimiliano Bonafè; Cristina Morsiani; Hwa Jin Jung; Liana Spazzafumo; Jose Viña; Yousin Suh
Journal:  Mech Ageing Dev       Date:  2016-12-13       Impact factor: 5.432

4.  BRLF1 suppresses RNA Pol III-mediated RIG-I inflammasome activation in the early EBV lytic lifecycle.

Authors:  Xubing Long; Jing Yang; Xiaolin Zhang; Ziwei Yang; Yang Li; Fan Wang; Xiaojuan Li; Ersheng Kuang
Journal:  EMBO Rep       Date:  2020-11-23       Impact factor: 9.071

Review 5.  DNA Oncogenic Virus-Induced Oxidative Stress, Genomic Damage, and Aberrant Epigenetic Alterations.

Authors:  Mankgopo Magdeline Kgatle; Catherine Wendy Spearman; Asgar Ali Kalla; Henry Norman Hairwadzi
Journal:  Oxid Med Cell Longev       Date:  2017-06-27       Impact factor: 6.543

6.  Parvovirus B19 induces cellular senescence in human dermal fibroblasts: putative role in systemic sclerosis-associated fibrosis.

Authors:  Rosaria Arvia; Krystyna Zakrzewska; Lisa Giovannelli; Sara Ristori; Elena Frediani; Mario Del Rosso; Alessandra Mocali; Maria A Stincarelli; Anna Laurenzana; Gabriella Fibbi; Francesca Margheri
Journal:  Rheumatology (Oxford)       Date:  2022-08-30       Impact factor: 7.046

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.